 |
PDBsum entry 2y7x
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Blood clotting
|
PDB id
|
|
|
|
2y7x
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Blood clotting
|
 |
|
Title:
|
 |
The discovery of potent and long-acting oral factor xa inhibitors with tetrahydroisoquinoline and benzazepine p4 motifs
|
|
Structure:
|
 |
Activated factor xa heavy chain. Chain: a. Synonym: coagulation factor x, stuart factor, stuart-prower factor. Other_details: disulphide linked to other chain. Factor x light chain. Chain: b. Fragment: activated desgla, residues 46-179. Synonym: coagulation factor x, stuart factor, stuart-prower factor. Other_details: disulphide linked to other chain
|
|
Source:
|
 |
Homo sapiens. Human. Organism_taxid: 9606. Other_details: purchased from enzyme research labs. Isolated from human blood. Human blood
|
|
Resolution:
|
 |
|
1.90Å
|
R-factor:
|
0.188
|
R-free:
|
0.230
|
|
|
Authors:
|
 |
N.S.Watson,C.Adams,D.Belton,D.Brown,C.L.Burns-Kurtis,L.Chaudry, C.Chan,M.A.Convery,D.E.Davies,A.M.Exall,J.D.Harling,W.R.Irving, S.Irvine,S.Kleanthous,I.M.Mclay,A.J.Pateman,A.N.Patikis,T.J.Roethka, S.Senger,G.J.Stelman,J.R.Toomey,R.I.West,C.Whittaker,P.Zhou, R.J.Young
|
|
Key ref:
|
 |
N.S.Watson
et al.
(2011).
The discovery of potent and long-acting oral factor Xa inhibitors with tetrahydroisoquinoline and benzazepine P4 motifs.
Bioorg Med Chem Lett,
21,
1588-1592.
PubMed id:
|
 |
|
Date:
|
 |
|
02-Feb-11
|
Release date:
|
16-Mar-11
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
Chains A, B:
E.C.3.4.21.6
- coagulation factor Xa.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
Preferential cleavage: Arg-|-Thr and then Arg-|-Ile bonds in prothrombin to form thrombin.
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
Bioorg Med Chem Lett
21:1588-1592
(2011)
|
|
PubMed id:
|
|
|
|
|
| |
|
The discovery of potent and long-acting oral factor Xa inhibitors with tetrahydroisoquinoline and benzazepine P4 motifs.
|
|
N.S.Watson,
C.Adams,
D.Belton,
D.Brown,
C.L.Burns-Kurtis,
L.Chaudry,
C.Chan,
M.A.Convery,
D.E.Davies,
A.M.Exall,
J.D.Harling,
S.Irvine,
W.R.Irving,
S.Kleanthous,
I.M.McLay,
A.J.Pateman,
A.N.Patikis,
T.J.Roethke,
S.Senger,
G.J.Stelman,
J.R.Toomey,
R.I.West,
C.Whittaker,
P.Zhou,
R.J.Young.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
');
}
}
 |
|